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Background:  Hemoconcentration (HC) during heart failure treatment is known to be associated with decreased mortality and 
rehospitalization in patients (pts) with acute decompensated heart failure (ADHF). On the other hand, progressive hyponatremia (pro-
hypoNa) during hospitalization is reported to be associated with poor outcome in ADHF pts. However, there is no information available on 
the long-term prognostic significance of prog-hypoNa during hospitalization in ADHF pts, relating to HC.
methods and results:  We studied 302 pts admitted with ADHF and discharged with survival. HC was defined as an increase in 
hemoglobin between admission and discharge. During a follow-up period of 5.0±4.3 yrs, 130 pts had cardiac events defined as 
hospitalization for worsening heart failure or cardiac death. HC (p=0.02) and pro-hypoNa, which was defined as higher degree of the 
maximum depression of serum sodium level after the admission (≥8mEq/L: the top quartile value) (p=0.03), were significantly associated 
with cardiac events, independently of renal dysfunction. In group without HC, pts with pro-hypoNa had a significantly higher risk of cardiac 
events than those without pro-hypoNa (67% vs 44%, p=0.003, HR: 2.1 [1.3-3.4]). On the other hand, in group without HC, there was no 
significant difference in the risk between pts with and without pro-hypoNa.
conclusion:  Progressive hyponatremia during heart failure treatment could provide the additional long-term prognostic information in 
ADHF pts without HC.
 
